RSS

SKTO SK3 Group Inc.

Last Post: 01/16/25
Followers: 60
Posts Today: 0
Views Today: 2028

SKTO Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Oct 29, 2:55 PM EST
Last0.0000
$ Chg0.0000
Open—
High—
Beta-22.0989
Year High0.000
Market Cap1.2K
P/B Ratio—
EPS—
Avg Vol (30d)11.6K
Volume0
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out1.24B
Float1.24B
ExchangeCV EM
Healthcare Pharmaceuticals

SKTO Stock Message Board Discussion

  1. theFutureisBright
  2. BLounz

Top 10 Most Recent News Articles

Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Rosti Group Expands with Alvi Acquisition

Updated Category News Views 105

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 35

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 193

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Nevada Organic Phosphate Plans Share Consolidation

Updated Category News Views 24

The Drill Down on Nevada Organic Phosphate's Strategic Moves There's a lot to unpack here as Nevada Organic Phosphate Inc. (CSE: NOP) rolls out its big game plan. They're looking to consolidate shares, flex their financial muscles, and maybe spray some high-octane fuel on their market positioning. Could be a smart move if they pull it off, but that's a big 'if' hanging in...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 91

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 381

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 510

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 105

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading

Top 5 Most Recently Viewed Articles

Pinnacle West Capital Corp Plans Q3 2024 Financial Update

Updated Category News Views 139

Pinnacle West Capital Corp Plans Q3 2024 Financial Update Pinnacle West Capital Corp. (NYSE: PNW) has announced its plans to release the third-quarter financial results for 2024 prior to the opening of the U.S. financial markets. This is a highly anticipated moment for investors and stakeholders, as the company seeks to share insights into its performance and the overall...

Continue Reading
Preferred Bank Advances Share Buyback Plan for Growth Strategy

Updated Category News Views 131

Preferred Bank Secures Regulatory Approval for Buyback Program Preferred Bank (NASDAQ: PFBC), an independent commercial bank operating primarily in California, has recently received the green light from regulatory bodies to proceed with its shareholder-backed $150 million stock repurchase plan. This momentous approval allows the bank to continue boosting shareholder value...

Continue Reading
Projected Growth and Trends in Yellow Phosphorus Market

Updated Category News Views 212

Understanding the Yellow Phosphorus & Derivatives Market The Yellow Phosphorus & Derivatives Market is a dynamic sector expected to reach USD 9.02 billion by the early 2030s, propelled by a steady compound annual growth rate (CAGR) of 5.34% from the mid-2020s onward. The driving forces behind this growth are multifaceted and reflect larger trends within agricultural and...

Continue Reading
Galiano Gold Reveals Impressive Q4 and Annual Financial Results

Updated Category News Views 260

Galiano Gold Shines With Robust Q4 and Full-Year Financial Results Galiano Gold Inc. (TSX: GAU) (NYSE American: GAU) recently unveiled its impressive production and financial outcomes for the fourth quarter and the entire year, showcasing the company’s strong performance and resilience. Galiano holds a significant interest in the Asanko Gold Mine (AGM), strategically...

Continue Reading
TetraScience Partners with Thermo Fisher for AI-Driven Innovation

Updated Category News Views 237

Enhancing Laboratory Efficiency Through AI Collaboration TetraScience, a leader in scientific data and AI solutions, has joined forces with Thermo Fisher Scientific, a prominent name in science services. This partnership aims to drive advancements in biopharmaceutical research and manufacturing, facilitating faster and more efficient scientific processes. Transforming...

Continue Reading